Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject&page=2
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject&page=2
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject&page=2
PubPharm (227)
11
Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine : Clinical Study on Immunogenicity and Safety of Recombinant Novel Coronavirus(COVID-19)Vaccine (CHO Cell) Combined With Tetravalent Influenza Virus Lysis Vaccine in People Aged 18 Years and Over
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
12
PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID) : PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
13
INACTIVATED SARS-COV-2 VACCINE (VERO CELL)PHASE III CLINICAL STUDY PROTOCOL : RANDOMIZED, DOUBLE BLIND, PARALLEL PLACEBO CONTROLLED, PHASE III CLINICAL TRIAL TO EVALUATE THE SAFETY AND PROTECTIVE EFFICACY OF INACTIVATED SARS-COV-2 VACCINE IN HEALTHY POPULATION AGED 18 YEARS AND ABOVE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
14
SOLIDARITY: AN INTERNATIONAL RANDOMIZED CONTROLLED TRIAL TO EVALUATE NON-LICENSED COVID-19 TREATMENTS IN ADDITION TO STANDARD OF CARE AMONG HOSPITALIZED PATIENTS : SOLIDARITY: AN INTERNATIONAL RANDOMIZED CONTROLLED TRIAL TO EVALUATE NON-LICENSED COVID-19 TREATMENTS IN ADDITION TO STANDARD OF CARE AMONG HOSPITALIZED PATIENTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
15
A PHASE 2/3, RANDOMIZED, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CT-P59 IN COMBINATION WITH STANDARD OF CARE IN OUTPATIENTS WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV-2) INFECTION : A PHASE 2/3, RANDOMIZED, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CT-P59 IN COMBINATION WITH STANDARD OF CARE IN OUTPATIENTS WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV-2) INFECTION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
16
LOSVID STUDY : A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF LOSMAPIMOD IN ADULT SUBJECTS WITH COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
17
RANDOMIZED MASTER PROTOCOL FOR IMMUNE MODULATORS FOR TREATING COVID-19 : RANDOMIZED MASTER PROTOCOL FOR IMMUNE MODULATORS FOR TREATING COVID-19SUBTITLE: ADDITION OF AN IMMUNOMODULATOR (INFLIXIMAB, ABATACEPT, OR CENICRIVIROC) TO STANDARD OF CARE FOR COVID-19 IN HOSPITALIZED PATIENTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
18
HERALD : COVID-19: A PHASE 2B/3, RANDOMIZED, OBSERVER-BLINDED, PLACEBO-CONTROLLED, MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF INVESTIGATIONAL SARS-COV-2 MRNA VACCINE CVNCOV IN ADULTS 18 YEARS OF AGE AND OLDER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
19
PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID) : PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
20
INACTIVATED SARS-COV-2 VACCINE (VERO CELL)PHASE III CLINICAL STUDY PROTOCOL : RANDOMIZED, DOUBLE BLIND, PARALLEL PLACEBO CONTROLLED, PHASE III CLINICAL TRIAL TO EVALUATE THE SAFETY AND PROTECTIVE EFFICACY OF INACTIVATED SARS-COV-2 VACCINE IN HEALTHY POPULATION AGED 18 YEARS AND ABOVE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Thema: Phase: Phase 3
Medienart
227
Aufsätze
227
E-Artikel
E-Ressourcen
Zeitschriftentitel
150
WHO International Clinical Trials Registry Plat...
77
ClinicalTrials.gov
Thema
227
610
Phase: Phase 3
227
Study Type: Interventional
77
Coronavirus Infections
77
Recruitment Status: Not yet recruiting
58
Recruitment Status: Authorised-recruitment may ...
32
Recruitment Status: Completed
30
COVID-19
26
Recruitment Status: Recruiting
20
Medical Condition: COVID-19 MedDRA version: 23....
18
Recruitment Status: Terminated
16
Medical Condition: Coronavirus disease 2019 (CO...
16
Medical Condition: Coronavirus disease 2019 (CO...
15
Severe Acute Respiratory Syndrome
14
Medical Condition: -B342 Coronavirus infection,...
12
Medical Condition: COVID-19 MedDRA version: 23....
10
Medical Condition: COVID-19 (Coronavirus Diseas...
10
Medical Condition: COVID-19 infection MedDRA ve...
9
Communicable Diseases
9
Infections
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2024
35
2023
43
2022
67
2021
77
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
223
Englisch
4
Unbestimmt
Haven't found what you're looking for?
Wird geladen...